Join to View Full Profile
930 Madison AveSuite 500Memphis, TN 38103
Phone+1 901-725-7551
Fax+1 901-725-9721
Are you Dr. Slominski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrzej Slominski, MD is a board certified pathologist in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee, Alabama, and New York. He is a Professor at University of Tennessee Health Science Center Coll.
Education & Training
Albany Medical CenterFellowship, Dermatopathology, 1996 - 1997- Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 1993 - 1997
Medical University of GdanskClass of 1979
Certifications & Licensure
NY State Medical License 1997 - 2026
TN State Medical License 2000 - 2026
AL State Medical License 2015 - 2025
American Board of Pathology Anatomic Pathology- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- Melatonin and the Skin: Current Progress and Perspectives for Human Health.Andrzej T Slominski, Tae-Kang Kim, Zorica Janjetovic, Radomir M Slominski, Gitali Ganguli-Indra
The Journal of Investigative Dermatology. 2025-02-06 - Corrigendum to "Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents" [Eur. J. Med. Chem. 220...Jingxuan Chen, Ling Li, Jin Liu, Sijie Yuan, Wenzhen Liao
European Journal of Medicinal Chemistry. 2024-10-05 - 26 citationsBiological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin.Andrzej T Slominski, Tae-Kang Kim, Zorica Janjetovic, Radomir M Slominski, Wei Li
The Journal of Investigative Dermatology. 2024-10-01
Press Mentions
Vitamin D Emerges as Possible Treatment for COVID-19September 9th, 2021- Skin Pigmentation Abnormalities and Their Possible Relationship with Skin AgingApril 2nd, 2021
Grant Support
- CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerBIRMINGHAM VA MEDICAL CENTER2019–2027
- CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerBIRMINGHAM VA MEDICAL CENTER2019–2027
- CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerBIRMINGHAM VA MEDICAL CENTER2019–2027
- CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerBIRMINGHAM VA MEDICAL CENTER2019–2027
- CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerBIRMINGHAM VA MEDICAL CENTER2019–2027
- CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerBIRMINGHAM VA MEDICAL CENTER2019–2027
- Mechanism of action and function of novel secosteroid 20(OH)D3 in the skinUNIVERSITY OF ALABAMA AT BIRMINGHAM2018–2025
- Mechanism of action and function of novel secosteroid 20(OH)D3 in the skinUNIVERSITY OF ALABAMA AT BIRMINGHAM2018–2025
